Clinic, neuropathology and molecular genetics of frontotemporal dementia: A mini-review

Translational Neurodegeneration

Volumn 2, Issue 1, 2013, Pages

  Pan, Xiao dong ^a   Chen, Xiao chun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

bvFTD; C9ORF72; GRN; Logopenic variant; MAPT; Molecular genetics; Nonfluent agrammatic variant; Semantic variant

Indexed keywords

TAU PROTEIN; UBIQUITIN;

CHROMOSOME 9 OPEN READING FRAME 72 GENE; CLINICAL FEATURE; DISEASE ASSOCIATION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GRANULIN GENE; HUMAN; IMAGE ANALYSIS; MICROTUBULE ASSOCIATED PROTEIN TAU GENE; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME DELINEATION;

EID: 84883601176     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-2-8     Document Type: Review

References (90)

1. Rossor MN. Pick's disease: a clinical overview. Neurology 2001, 56:S3-S5. 10.1212/WNL.56.suppl_4.S3, 11402142.
2. Snowden JS, Neary D, Mann DM. Frontotemporal dementia. Br J Psychiatry 2002, 180:140-143. 10.1192/bjp.180.2.140, 11823324.
3. The Lund and Manchester Groups Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994, 57:416-418. 1072868, 8163988, The Lund and Manchester Groups.
4. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554. 10.1212/WNL.51.6.1546, 9855500.
5. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002, 58:1615-1621. 10.1212/WNL.58.11.1615, 12058088.
6. Arvanitakis Z. Update on frontotemporal dementia. Neurologist 2010, 16:16-22. 10.1097/NRL.0b013e3181b1d5c6, 3632348, 20065792.
7. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002, 16:203-212. 10.1097/00002093-200210000-00001, 12468894.
8. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003, 126:2016-2022. 10.1093/brain/awg204, 12876142.
9. Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008, 71:1496-1499. 10.1212/01.wnl.0000334277.16896.fa, 18981371.
10. Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004, 17:265-268. 10.1159/000077151, 15178933.
11. Hou CE, Yaffe K, Perez-Stable EJ, Miller BL. Frequency of dementia etiologies in four ethnic groups. Dement Geriatr Cogn Disord 2006, 22:42-47. 10.1159/000093217, 16682792.
12. Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 2005, 62:925-930. 10.1001/archneur.62.6.925, 15956163.
13. Piguet O, Hornberger M, Mioshi E, Hodges JR. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 2011, 10:162-172. 10.1016/S1474-4422(10)70299-4, 21147039.
14. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 2010, 67:826-830. 10.1001/archneurol.2010.146, 20625088.
15. Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 2011, 122:137-153. 10.1007/s00401-011-0839-6, 3232515, 21614463.
16. Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001, 103:367-378. 10.1034/j.1600-0404.2001.2000236.x, 11421849.
17. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134:2456-2477. 10.1093/brain/awr179, 3170532, 21810890.
18. Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011, 134:2565-2581. 10.1093/brain/awr198, 3170537, 21908872.
19. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 2010, 6:88-97. 10.1038/nrneurol.2009.216, 20139998.
20. Irwin DJ, McMillan CT, Toledo JB, Arnold SE, Shaw LM, Wang LS, Van Deerlin V, Lee VM, Trojanowski JQ, Grossman M. Comparison of cerebrospinal fluid levels of tau and Abeta 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol 2012, 69:1018-1025. 10.1001/archneurol.2012.26, 22490326.
21. Verwey NA, Kester MI, van der Flier WM, Veerhuis R, Berkhof H, Twaalfhoven H, Blankenstein MA, Scheltens AP, Pijnenburg YA. Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects. J Alzheimers Dis 2010, 20:445-452.
22. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014. 10.1212/WNL.0b013e31821103e6, 3059138, 21325651.
23. Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011, 134:2478-2492. 10.1093/brain/awr189, 21840888.
24. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, Perani D, Garibotto V, Cappa SF, Miller BL. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008, 71:1227-1234. 10.1212/01.wnl.0000320506.79811.da, 2676989, 18633132.
25. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008, 64:388-401. 10.1002/ana.21451, 2648510, 18991338.
26. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007, 6:994-1003. 10.1016/S1474-4422(07)70265-X, 17945153.
27. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005, 65:586-590. 10.1212/01.wnl.0000172911.39167.b6, 16116120.
28. van Langenhove T, van der Zee J, van Broeckhoven C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med 2012, 44:817-828. 10.3109/07853890.2012.665471, 3529157, 22420316.
29. Soma K, Fu YJ, Wakabayashi K, Onodera O, Kakita A, Takahashi H. Co-occurrence of argyrophilic grain disease in sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2012, 38:54-60. 10.1111/j.1365-2990.2011.01175.x, 21702760.
30. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998, 8:387-402.
31. Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain 2008, 131:1416-1432. 10.1093/brain/awm305, 18234698.
32. Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 2009, 132:2579-2592. 10.1093/brain/awp071, 2732263, 19439421.
33. Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, Jackson A, Neary D. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 2002, 105:261-269. 10.1034/j.1600-0404.2002.1o148.x, 11939938.
34. Kanda T, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Kono AK, Mori E. Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging 2008, 35:2227-2234. 10.1007/s00259-008-0871-5, 18661129.
35. Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 2012, 11:545-555. 10.1016/S1474-4422(12)70099-6, 22608668.
36. Grossman M, Powers J, Ash S, McMillan C, Burkholder L, Irwin D, Trojanowski JQ. Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang 2012, in Press, doi: 10.1016/j.bandl.2012.10.005. [Epub ahead of print], PMID: 23218686.
37. Hu WT, McMillan C, Libon D, Leight S, Forman M, Lee VM, Trojanowski JQ, Grossman M. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 2010, 75:595-602. 10.1212/WNL.0b013e3181ed9c52, 2931765, 20713948.
38. Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Langstrom B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 2008, 35:100-106. 10.1007/s00259-007-0523-1, 17846768.
39. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D. Imaging beta-amyloid burden in aging and dementia. Neurology 2007, 68:1718-1725. 10.1212/01.wnl.0000261919.22630.ea, 17502554.
40. Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, Rigopoulos A, Cartwright GA, O'Keefe G. 18 F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain 2011, 134:1089-1100. 10.1093/brain/awr038, 21436112.
41. Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003, 60:1005-1011. 10.1212/01.WNL.0000052685.09194.39, 12654969.
42. Kersaitis C, Halliday GM, Kril JJ. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 2004, 108:515-523. 10.1007/s00401-004-0917-0, 15368070.
43. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010, 9:995-1007. 10.1016/S1474-4422(10)70195-2, 20864052.
44. Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 2011, 43:699-705. 10.1038/ng.859, 3125476, 21685912.
45. Boeve BF. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci 2011, 45:350-353. 10.1007/s12031-011-9624-1, 21853287.
46. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009, 117:15-18. 10.1007/s00401-008-0460-5, 2710877, 19015862.
47. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, Legallic S, Salachas F, Hannequin D, Decousus M. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009, 65:470-473. 10.1002/ana.21612, 19350673.
48. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133. 10.1126/science.1134108, 17023659.
49. Mackenzie IR, Foti D, Woulfe J, Hurwitz TA. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 2008, 131:1282-1293.
50. Grossman M, Wood EM, Moore P, Neumann M, Kwong L, Forman MS, Clark CM, McCluskey LF, Miller BL, Lee VM. TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol 2007, 64:1449-1454. 10.1001/archneur.64.10.1449, 17923628.
51. Mackenzie IR, Munoz DG, Kusaka H, Yokota O, Ishihara K, Roeber S, Kretzschmar HA, Cairns NJ, Neumann M. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol 2011, 121:207-218. 10.1007/s00401-010-0764-0, 21052700.
52. Roeber S, Mackenzie IR, Kretzschmar HA, Neumann M. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol 2008, 116:147-157. 10.1007/s00401-008-0395-x, 18536926.
53. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009, 73:1451-1456. 10.1212/WNL.0b013e3181bf997a, 2779007, 19884572.
54. Giannakopoulos P, Hof PR, Bouras C. Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases. Acta Neuropathol 1995, 89:346-355. 10.1007/BF00309628, 7610766.
55. Josephs KA, Jones AG, Dickson DW. Hippocampal sclerosis and ubiquitin-positive inclusions in dementia lacking distinctive histopathology. Dement Geriatr Cogn Disord 2004, 17:342-345. 10.1159/000077168, 15178950.
56. Gainotti G. Different patterns of famous people recognition disorders in patients with right and left anterior temporal lesions: a systematic review. Neuropsychologia 2007, 45:1591-1607. 10.1016/j.neuropsychologia.2006.12.013, 17275042.
57. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 2010, 24:375-398. 10.2165/11533100-000000000-00000, 2916644, 20369906.
58. Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT, Boeve BF, Graff-Radford NR, Parisi JE, Knopman DS. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 2008, 70:25-34. 10.1212/01.wnl.0000287073.12737.35, 2749307, 18166704.
59. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, Weintraub S, Bigio EH. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008, 63:709-719. 10.1002/ana.21388, 2858311, 18412267.
60. Rohrer JD, Rossor MN, Warren JD. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2012, 33:744-752. 10.1016/j.neurobiolaging.2010.05.020, 3314936, 20580129.
61. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005, 4:771-780. 10.1016/S1474-4422(05)70223-4, 16239184.
62. Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM, Grossman M. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005, 65:1817-1819. 10.1212/01.wnl.0000187068.92184.63, 16344531.
63. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705. 10.1038/31508, 9641683.
64. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004, 36:377-381. 10.1038/ng1332, 15034582.
65. Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 2001, 3:740-744. 10.1038/35087056, 11483959.
66. Holm IE, Isaacs AM, Mackenzie IR. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 2009, 118:719-720. 10.1007/s00401-009-0593-1, 19844732.
67. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005, 37:806-808. 10.1038/ng1609, 16041373.
68. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919. 10.1038/nature05016, 16862116.
69. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006, 15:2988-3001. 10.1093/hmg/ddl241, 16950801.
70. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256. 10.1016/j.neuron.2011.09.011, 3202986, 21944778.
71. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. 10.1016/j.neuron.2011.09.010, 3200438, 21944779.
72. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012, 11:323-330. 10.1016/S1474-4422(12)70043-1, 3322422, 22406228.
73. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 2012, 11:54-65. 10.1016/S1474-4422(11)70261-7, 22154785.
74. Whitwell JL, Xu J, Mandrekar J, Boeve BF, Knopman DS, Parisi JE, Senjem ML, Dickson DW, Petersen RC, Rademakers R. Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging 2012, 34:636-639.
75. Arighi A, Fumagalli GG, Jacini F, Fenoglio C, Ghezzi L, Pietroboni AM, De Riz M, Serpente M, Ridolfi E, Bonsi R. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J Alzheimers Dis 2012, 31:447-452.
76. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobagyi T, Shaw CE. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 2011, 122:691-702. 10.1007/s00401-011-0911-2, 22101323.
77. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 2012, 135:765-783. 10.1093/brain/aws004, 3286335, 22366793.
78. Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, De Deyn PP, Santens P, Van Broeckhoven C, Cruts M. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 2012, 124:353-372. 10.1007/s00401-012-1029-x, 3422616, 22890575.
79. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Zuchner S, Konidari I, Wang G. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010, 74:97-109. 10.1111/j.1469-1809.2009.00560.x, 2853717, 20070850.
80. Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 2004, 24:277-295. 10.1002/humu.20086, 15365985.
81. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011, 122:111-113. 10.1007/s00401-011-0845-8, 3285143, 21644037.
82. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl) 2003, 81:600-612.
83. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 2008, 181:37-41. 10.1083/jcb.200712039, 2287280, 18378771.
84. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, Beal MF. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 2010, 207:117-128. 10.1084/jem.20091568, 2812536, 20026663.
85. Weihl CC, Pestronk A, Kimonis VE. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul Disord 2009, 19:308-315. 10.1016/j.nmd.2009.01.009, 2859037, 19380227.
86. Ju JS, Weihl CC. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy 2010, 6:283-285. 10.4161/auto.6.2.11063, 2997346, 20083896.
87. Ju JS, Weihl CC. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet 2010, 19:R38-R45. 10.1093/hmg/ddq157, 2875057, 20410287.
88. Suzuki M, Lee HC, Kayasuga Y, Chiba S, Nedachi T, Matsuwaki T, Yamanouchi K, Nishihara M. Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis. J Reprod Dev 2009, 55:351-355. 10.1262/jrd.20249, 2739127, 19721334.
89. Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am J Pathol 2010, 177:311-324. 10.2353/ajpath.2010.090915, 2893674, 20522652.
90. Gijselinck I, Van Broeckhoven C, Cruts M. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum Mutat 2008, 29:1373-1386. 10.1002/humu.20785, 18543312.